Resmed

Forecast & Rating20 analysts currently cover Resmed, with about 35.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $245.50, about 5.6% upside from the current price of $232.45. Price targets range from $175.00 to $320.00 — a wide spread, showing clear disagreement over just how much Resmed can rise. Historically, about 59.3% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Resmed's outlook. Data as of Aug 20, 2026; for reference only and not investment advice.